TGF-β1-Binding Proteins on Human Bone Marrow Stromal Cells

References

• Dorshkind K. Regulation of hematopoiesis by bone marrow stromal cells and their products. Ann. Rev. Immunol. 1990; 8: 111–137
   PubMed Web of Science ®Google Scholar
• Eaves C. J., Cashman J. D., Kay R. J., Dougherty G. J., Otsuka T., Gaboury L. A., Hogge D. E., Lansdorp P. M., Eaves A. C., Humphries R. K. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long‐term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 1991; 78: 110–117
   PubMed Web of Science ®Google Scholar
• Deryugina E. I., Müller‐Sieburg C. E. Stromal cells in long‐term cultures: keys to the elucidation of hematopoietic development?. Crit. Rev. Immunol. 1993; 13: 115–150
   PubMed Web of Science ®Google Scholar
• Dexter T. M., Allen T. D., Lajtha I. G. Conditions controlling the proliferation of hematopoietic stem cells in vitro. J. Cell. Physiol. 1977; 91: 335–344
   PubMed Web of Science ®Google Scholar
• Whitlock C. A., Witte O. N. Long‐term culture of B lymphocytes and their precursors from murine bone marrow. Proc. Nat. Acad. Sci. USA. 1982; 79: 3608–3612
   PubMed Web of Science ®Google Scholar
• Brunner G., Gabrilove J., Rifkin D. B., Wilson E. L. Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol‐anchored heparan sulfate proteoglycan. J. Cell Biol. 1991; 114: 1275–1283
   PubMed Web of Science ®Google Scholar
• Abboud S. L. A bone marrow stromal cell line is a source and target for platelet‐derived growth factor. Blood 1993; 81: 2547–2553
   PubMed Web of Science ®Google Scholar
• Abboud S. L., Pinzani M. Peptide growth factors stimulate macrophage colony‐stimulating factor in murine stromal cells. Blood 1991; 78: 103–109
   PubMed Web of Science ®Google Scholar
• Keller U., Aman M. J., Derigs G., Huber C., Peschel C. Human interleukin‐4 enhances stromal cell‐dependent hematopoiesis: coestimulation with stem cell factor. Blood 1994; 84: 2189–2196
   PubMed Web of Science ®Google Scholar
• Gronthos S., Simmons P. J. The growth factor requirements of STRO‐1‐positive human bone marrow stromal precursors under serum‐deprived conditions in vitro. Blood 1995; 85: 929–940
   PubMed Web of Science ®Google Scholar
• Dooley D. C., Oppenlander B. K., Spurgin P., Mead J. H., Novak P., Plunkett M., Beckstead J., Heinrich M. C. Basic fibroblasts growth factor and epidermal growth factor down‐modulate the growth of hematopoietic cells in long‐term stromal cultures. J. Cell. Physiol. 1995; 165: 386–397
   PubMed Web of Science ®Google Scholar
• Deryugina E. I., Ratnikov B. I., Bourdon M. A., Gilmore G. L., Shadduck R. K., Müller‐Sieburg C. E. Identification of a growth factor for primary murine stroma as macrophage colony‐stimulating factor. Blood 1995; 86: 2568–2578
   PubMed Web of Science ®Google Scholar
• Bhatia R., McGlave P. B., Verfaillie C. M. Treatment of marrow stroma with interferon‐α restores normal β1 integrin‐dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. J. Clin. Invest. 1995; 96: 931–939
   PubMed Web of Science ®Google Scholar
• Gautam S. C., Pindolia K. R., Noth C. J., Janakiraman N., Xu Y. X., Chapman R. A. Chemokine gene expression in bone marrow stromal cells: Down‐regulation with sodium salicylate. Blood 1995; 86: 2451–2550
   PubMedGoogle Scholar
• Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11–25
   PubMed Web of Science ®Google Scholar
• Ryan D. H., Nuccie B. L., Abbound C. N., Winslow J. M. Vascular cell adhesion molecule‐1 and integrin VLA‐4 mediate adhesion of human B‐cell precursors to cultured bone marrow adherent cells. J. Clin. Invest. 1991; 88: 995–1004
   PubMed Web of Science ®Google Scholar
• Teixidó J., Hemler M. E., Greenberger J. S., Anklesaria P. Role of β1 and β2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J. Clin. Invest. 1992; 90: 358–367
   PubMed Web of Science ®Google Scholar
• Kingsley D. M. The TGF‐β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Trends in Genet. 1994; 10: 16–21
   PubMed Web of Science ®Google Scholar
• Massagué J., Polyak K. Mammalian antiproliferative signals and their targets. Curr. Op. Genet. Develop. 1995; 5: 91–96
   PubMedGoogle Scholar
• Massagué J. TGF‐β signaling: receptors, transducers, and mad proteins. Cell 1996; 85: 947–950
   PubMed Web of Science ®Google Scholar
• Attisano L., Wrana J. L., López‐Casillas F., Massagué J. TGF‐β receptors and actions. Biochem. Biophvs. Acta 1994; 1222: 71–80
   PubMed Web of Science ®Google Scholar
• Gougos A., Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre‐B leukemic cell line. J. Immunol. 1988a; 141: 1925–1933
   PubMed Web of Science ®Google Scholar
• Gougos A., Letarte M. Biochemical characterization of the 44G4 antigen from the Hoon pre‐B leukemic cell line. J. Immunol. 1988b; 141: 1934–1940
   PubMed Web of Science ®Google Scholar
• Gougos A., Letarte M. Primary structure of endoglin, an RGD‐containing glycoprotein of human endothelial cells. J. Biol. Chem. 1990; 265: 8361–8364
   PubMed Web of Science ®Google Scholar
• Cheifetz S., Bellón T., Calés C., Vera S., Bernabeu C., Massagué J., Letarte M. Endoglin is a component of the transforming growth factor‐β receptor system in human endothelial cells. J. Biol. Chem. 1992; 267: 19027–19030
   PubMed Web of Science ®Google Scholar
• Yamashita H., Ichijo H., Grimsby S., Morén A., ten Dijke P., Miyazono K. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor‐β. J. Biol. Chem. 1994; 269: 1995–2001
   PubMed Web of Science ®Google Scholar
• Lastres P., Martin‐Pérez J., Langa C., Bernabeu C. Phosphorylation of the human‐transforming‐growth‐factor‐binding protein endoglin. Biochem. J. 1994; 301: 765–768
   PubMed Web of Science ®Google Scholar
• McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Murrell J., McCorminck M. K., Pericak‐Vance M. A., Heutink P., Oostra B. A., Haitjema T., Westerman C. J. J., Porteus M. E., Guttmacher A. E., Letarte M., Marchuk D. A. Endoglin, a TGF‐β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genet. 1994; 8: 345–351
   PubMed Web of Science ®Google Scholar
• Fava R. A., Casey T. T., Wilcox J., Pelton R. W., Moses H. L., Nanney L. B. Synthesis of transforming growth factor‐β1 by megakaryocytes and its localization to megakaryocyte and platelet α‐granules. Blood 1990; 76: 1946–1955
   PubMed Web of Science ®Google Scholar
• Gimble J. M., Pietrangeli C., Henley A., Dorheim M. A., Silver J., Namen A., Takeichi M., Goridis C., Kincade P. W. Characterization of murine bone marrow and spleen‐derived stromal cells: analysis of leucocyte marker and growth factor mRNA transcript levels. Blood 1989; 74: 303–311
   PubMed Web of Science ®Google Scholar
• Ohta M., Greenberger J. S., Anklesaria P., Bassols A., Massagué J. Two forms of transforming growth factor‐β distinguished by multipotential hematopoietic progenitor cells. Nature 1987; 329: 539–541
   PubMed Web of Science ®Google Scholar
• Hampson J., Ponting I. L. O., Cook N., Vodinelich N., Redmond S., Roberts A. B., Dexter T. M. The effect of TGF‐β on hematopoietic cells. Growth Factors 1988; 1: 193–202
   Google Scholar
• Hino M., Tojo A., Miyazono K., Miura Y., Urabe A., Takaku F. Effects of type β transforming growth factors on hematopoietic progenitor cells. Brit. J. Haematol 1989; 70: 143–147
   Web of Science ®Google Scholar
• Ottmann O. G., Pelus L. M. Differential proliferative effects of transforming growth factor β on human hematopoietic progenitor cells. J. Immunol. 1988; 140: 2661–2665
   PubMed Web of Science ®Google Scholar
• Keller J. R., Jacobsen S. E., Sill K. T., Ellingsworth L. R., Ruscetti F. W. Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte/macrophage‐colony stimulating factor. Proc. Natl. Acad. Sci. USA 1991; 88: 7190–7194
   PubMed Web of Science ®Google Scholar
• Jacobsen F. W., Stokke T., Jacobsen S. E. W. Transforming growth factor‐β potently inhibits the viability‐promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 1995; 86: 2957–2966
   PubMed Web of Science ®Google Scholar
• Ohishi K., Katayama N., Itoh R., Mahmud N., Miwa H., Kita K., Minami N., Shirakawa S., Lyman S., Shiku H. Accelerated cell cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor‐β. Blood 1996; 87: 1718–1727
   PubMed Web of Science ®Google Scholar
• Lagneaux L., Delforge A., Dorval C., Bron D., Stryckmans. Excessive production of transforming growth factor‐β by bone marrow stromal cells in B‐cell chronic lymphocyte leukemia inhibits growth of hematopoietic precursors and interleukin‐6 production. Blood 1993; 82: 2379–2385
   PubMed Web of Science ®Google Scholar
• Urashima M., Ogata A., Chuhan D., Hatziyanni M., Vidriales M. B., Dedera D. A., Schlossman R. L., Anderson K. C. Transforming growth factor‐β1: Differential effects on multiple myeloma versus normal B‐cells. Blood 1996; 87: 1928–1938
   PubMed Web of Science ®Google Scholar
• Robledo M. M., Hidalgo A., Lastres P., Arroyo A. G., Bernabeu C., Sánchez‐Madrid F., Teixidó J. Characterization of TGF‐β1‐binding proteins in human bone marrow stromal cells. Brit. J. Hematol 1996; 93: 507–514
   PubMed Web of Science ®Google Scholar
• Wilkins B. S., Jones D. B. Immunohistochemical characterization of intact stromal layers in long‐term cultures of human bone marrow. Brit. J. Hematol. 1994; 90: 757–766
   Web of Science ®Google Scholar
• Rokhlin O. W., Cohen M. B., Kubagawa H., Letarte M., Cooper M. D. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J. Immunol. 1995; 154: 4456–4465
   PubMed Web of Science ®Google Scholar
• Wahl S. M., Hunt D. E., Wakefield L. M., McCartney‐Francis N., Wahl L. M., Roberts A. B., Sporn M. B. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Nat. Acad. Sci. USA 1987; 84: 5788–5792
   PubMed Web of Science ®Google Scholar
• Heinrich M. C., Dooley D. C., Keeble W. W. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c‐kit). Blood 1995; 85: 1769–1780
   PubMed Web of Science ®Google Scholar
• Gimble J. M., Hudson J., Henthorn J., Hua X. X., Burstein S. A. Regulation of interleukin 6 expression in murine bone marrow stromal cells. Exp. Hematol. 1991; 19: 1055–1060
   PubMed Web of Science ®Google Scholar
• Musso T., Espinoza‐Delgado I., Pulkki K., Gusella G. L., Longo D. L., Varesio L. Transforming growth factor beta down‐regulates interleukin‐1 (IL‐l)‐induced IL‐6 production by human monocytes. Blood 1990; 76: 2466–2469
   PubMed Web of Science ®Google Scholar
• Dubois C. M., Ruscetti F. W., Palaszynski E. W., Falk L. A., Oppenheim J. J., Keller J. R. Transforming growth factor β is a potent inhibitor of interleukin 1 (IL‐1) receptor expression: Proposed mechanism of inhibition of IL‐1 action. J. Exp. Med. 1990; 172: 737–744
   PubMed Web of Science ®Google Scholar
• Yamakage A., Kikuchi K., Smith E. A., LeRoy C. L., Trojanowska M. Selective upregulation of platelet‐derived growth factor α receptors by transforming growth factor β in scleroderma fibroblasts. J. Exp. Med. 1992; 175: 1227–1234
   PubMed Web of Science ®Google Scholar
• Dubois C. M., Ruscetti F. W., Stankova J., Keller J. R. Transforming growth factor‐β regulates c‐kit message stability and cell‐surface protein expression in hematopoietic progenitors. Blood 1994; 83: 3138–3145
   PubMed Web of Science ®Google Scholar
• Sansilvestri P., Cardoso A. A., Batard P., Panterne B., Hatzfeld A., Lim B., Lévesque J. ‐P., Monier M. ‐N., Hatzfeld J. Early CD34high cells can be separated into KIThigh cells in which transforming growth factor‐β (TGF‐β) down‐modulates c‐kit and KITlow cells in which anti‐TGF‐β upmodulates c‐kit. Blood 1995; 86: 1729–1735
   PubMed Web of Science ®Google Scholar
• Yang Y. C., Tsai S., Wong G. G., Clark S. C. Interleukin‐1 regulation of hematopoietic growth factor production by human stromal fibroblasts. J. Cell. Physiol. 1988; 134: 292–296
   PubMed Web of Science ®Google Scholar
• Slack J. L., Nemunaitis J., Andrews D. F., Singer J. W. Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simiam virus 40. Blood 1990; 75: 2319–2327
   PubMed Web of Science ®Google Scholar
• Bascom C. C., Wolfshohl J. R., Coffey R. J., Madisen L., Webb N. R., Purchio A. R., Derynck R., Moses H. L. Complex regulation of transforming growth factor β1, β2 and β3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors β1 and β2. Mol. Cel. Biol 1989; 9: 5508–5515
   PubMed Web of Science ®Google Scholar
• Ignotz R. A., Massagué J. Transforming growth factor‐β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 1986; 261: 4337–4345
   PubMed Web of Science ®Google Scholar
• Williams D. A., Ríos M., Stephens C., Patel V. P. Fibronectin and VLA‐4 in haematopoietic stem cell‐microenvironment interactions. Nature 1991; 352: 438–441
   PubMed Web of Science ®Google Scholar
• Hurley R. W., McCarthy J. B., Verfaille C. M. Direct adhesion to bone marrow stroma via fibronection receptors inhibits haematopoietic progenitor proliferation. J. Clin. Invest. 1995; 96: 511–519
   PubMed Web of Science ®Google Scholar
• Kinashi T., Springer T. A. Steel factor and c‐kit regulate cell‐matrix adhesion. Blood 1994; 83: 1033–1038
   PubMed Web of Science ®Google Scholar
• Kovach N. L., Lin N., Yednock T., Harlan J. M., Broudy V. C. Stem cell factor modulates avidity of α4β1 and α5β1 integrins expressed on hematopoietic cell lines. Blood 1995; 85: 159–167
   PubMed Web of Science ®Google Scholar
• Lévesque J. ‐P., Leavesley D. I., Niutta S., Vadas M., Simmons P. J. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)‐4 and VLA‐5 integrins. J. Exp. Med. 1995; 181: 1805–1815
   PubMed Web of Science ®Google Scholar
• Dittel B. N., McCarthy J. B., Wayner E. A., Le Bien T. W. Regulation of human B‐cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule‐1 (VCAM‐1). Blood 1993; 81: 2272–2282
   PubMed Web of Science ®Google Scholar
• Maltman J., Pragnell I. B., Graham G. J. Specificity and reciprocity in the interactions between TGF‐β and macrophage inflammatory protein‐1α. J. Immunol. 1996; 156: 1566–1571
   PubMed Web of Science ®Google Scholar
• Pozo M. A., delSánchez‐Mateos P., Nieto M., Sánchez‐Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J. Cell Biol. 1995; 131: 495–508
   PubMed Web of Science ®Google Scholar
• Weber C., Alon R., Moser B., Springer T. A. Sequential regulation of α4β1 and α5β1 integrin avidity by CC chemokines in monocytes: Implications for transendothelial chemotaxis. J. Cell Biol. 1996; 134: 1063–1073
   PubMed Web of Science ®Google Scholar